Cook Ireland, Ltd. appears in FDA premarket approval records as the applicant for two cardiovascular stent PMAs and their later supplements. The supplied collection holds four linked PMA records: two original approvals and two 30-day notices decided on the same date. The filings identify the applicant at an address on O'Halloran Road, National Technology Park, Limerick; that is a filing address, and no headquarters location is established here. The records cover iliac and superficial femoral artery stent product codes, both under the Cardiovascular advisory committee. [1][3][4]

The Zilver PTX drug-eluting stent

P100022 covers the Zilver® PTX® Drug-Eluting Peripheral Stent, product code NIU, generic name "Stent, superficial femoral artery, drug-eluting." FDA approved the original application on 2012-11-14 after receipt on 2010-06-04, with a Federal Register notice date of 2012-11-30. The approval order describes the device as intended to improve luminal diameter in de novo or restenotic symptomatic lesions of native above-the-knee femoropopliteal arteries. [3]

The instructions for use, published by Cook, describe the device as a self-expanding stent made of nitinol and coated with the drug paclitaxel, intended for permanent implant, and as a flexible, slotted tube. The same document carries a prescription-use caution and lists ethylene oxide sterilization, single-use and shelf-life labeling symbols, and names Cook Ireland Ltd. at O'Halloran Road, National Technology Park, Limerick. [7]

The Zilver vascular stents

P050017 covers the Zilver 635 Vascular Stent and Zilver 518 Vascular Stent, product code NIO, generic name "Stent, Iliac." FDA approved the original application on 2006-06-26 after receipt on 2005-04-15, with a Federal Register notice date of 2006-07-26. The approval order describes the device as an adjunct to percutaneous transluminal angioplasty for symptomatic vascular disease of the iliac arteries. [4]

2026 packaging process supplements

Two 30-day notices were received on 2026-10-08 and decided OK30 on 2026-11-06. P100022/S046 is a process change for manufacturer, sterilizer, packager or supplier, and its approval order statement covers new equipment used for manufacturing packaging for the Zilver® PTX® Drug-Eluting Peripheral Stent and Zilver® Vascular Stent. P050017/S027 carries the same supplement reason and the same approval order statement wording. [1][2]

Both supplements sit under the Cardiovascular advisory committee and neither carries an expedited review flag. They are manufacturing and packaging process notices tied to already-approved PMAs, not new device approvals. The supplied collection counts four linked PMA records, split between two APPR and two OK30 decisions; these are counts of the supplied filings as of the snapshot date, not measures of total portfolio, sales or safety performance. [1][2]

Applicant identity and published materials

Cook Ireland, Ltd. is the applicant named on all four supplied PMA records, and the instructions for use lists COOK IRELAND LTD. as the manufacturer contact. Cook Medical's product pages for Zilver PTX carry a 2026 copyright notice and a statement that not all products shown may be approved in all regulatory jurisdictions, directing readers to a local Cook representative, distributor or customer support center. Those pages do not establish ownership of Cook Ireland, Ltd. by any parent entity, and no such relationship is verified in the public documents. [7][8][10]